posteditor

posteditor

MARKING MAJOR MILESTONE OF 100,000 PATIENTS TREATED, NORDIC PHARMA, INC. (U.S.) ENHANCES ITS OFFERING AND INCREASES PROVIDER CONVENIENCE BY INCLUDING CANNULAS WITH ITS SHIPMENTS OF LACRIFILL® CANALICULAR GEL FOR TREATMENT OF DRY EYE SYMPTOMS

B Nordic Pharma, Inc. is demonstrating this novel therapy at ASCRS BERWYN, Pa., April 9, 2026 /PRNewswire/ — Nordic Pharma, Inc., a subsidiary of Nordic Group… Login to continue reading Login Sign up for complimentary access Sign Up Now Close